These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32782117)

  • 1. Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
    Gorabi AM; Kiaie N; Aslani S; Jamialahmadi T; Johnston TP; Sahebkar A
    J Autoimmun; 2020 Nov; 114():102529. PubMed ID: 32782117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.
    von Eije KJ; Berkhout B
    Antivir Chem Chemother; 2009; 19(6):221-33. PubMed ID: 19641231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases.
    Germain ND; Chung WK; Sarmiere PD
    Mol Aspects Med; 2023 Jun; 91():101148. PubMed ID: 36257857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfering with disease: opportunities and roadblocks to harnessing RNA interference.
    Lieberman J; Song E; Lee SK; Shankar P
    Trends Mol Med; 2003 Sep; 9(9):397-403. PubMed ID: 13129706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
    Traber GM; Yu AM
    J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic face of RNAi: in vivo challenges.
    Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
    Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference: from gene silencing to gene-specific therapeutics.
    Leung RK; Whittaker PA
    Pharmacol Ther; 2005 Aug; 107(2):222-39. PubMed ID: 15908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference--a silent but an efficient therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi and miRNA in viral infections and cancers.
    Mollaie HR; Monavari SH; Arabzadeh SA; Shamsi-Shahrabadi M; Fazlalipour M; Afshar RM
    Asian Pac J Cancer Prev; 2013; 14(12):7045-56. PubMed ID: 24460249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA, miRNA, and shRNA: in vivo applications.
    Pushparaj PN; Aarthi JJ; Manikandan J; Kumar SD
    J Dent Res; 2008 Nov; 87(11):992-1003. PubMed ID: 18946005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.
    Guzman-Aranguez A; Loma P; Pintor J
    Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.
    Farra R; Grassi M; Grassi G; Dapas B
    World J Gastroenterol; 2015 Aug; 21(30):8994-9001. PubMed ID: 26290628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.
    Poller W; Fechner H
    Curr Pharm Des; 2010; 16(20):2252-68. PubMed ID: 20459390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
    De Paula D; Bentley MV; Mahato RI
    RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.